|Bid||0.0000 x 3200|
|Ask||0.0000 x 2900|
|Day's Range||3.7600 - 4.1000|
|52 Week Range||2.7700 - 5.7400|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 04, 2022 - May 09, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for CHMA
Chiasma, Inc. ( NASDAQ:CHMA ) is possibly approaching a major achievement in its business, so we would like to shine...
Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced the appointment of Anand Varadan to its Board of Directors, effective July 26, 2021. Mr. Varadan brings expertise in commercialization and successful product launches. In addition, Mark Iwicki stepped down from his role on the Board of Directors effective July 23, 2021.
NEW YORK, July 24, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Raven Industries, Inc. (NASDAQ: RAVN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to CNH Industrial N.V. for $58.00 per share. If you are a Raven shareholder, click here to learn more about your rights and options. Bank of Commerce Holdings (NASDAQ: BOCH) concerning poten